Otsu, Japan

Takeshi Kodama

USPTO Granted Patents = 4 


Average Co-Inventor Count = 18.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Otsu, JP (2012)
  • Osaka, JP (2013)

Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Takeshi Kodama

Introduction

Takeshi Kodama is a prominent inventor based in Otsu, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing innovative compounds that have the potential to impact medical treatments.

Latest Patents

Among his latest patents, Kodama has developed a heterocyclic compound and a pharmaceutical composition thereof. This invention provides a heterocyclic compound represented by General Formula (1). Another notable patent is the STAT3/5 activation inhibitor, which aims to provide an inhibitor containing an aromatic compound represented by a specific general formula or a salt thereof as an active ingredient. This compound is designed to target specific groups and structures, showcasing Kodama's expertise in medicinal chemistry.

Career Highlights

Takeshi Kodama is currently employed at Otsuka Pharmaceutical Company, Limited. His role at this esteemed organization allows him to collaborate with other talented professionals in the field. His contributions to the company have been instrumental in advancing their research and development efforts.

Collaborations

Kodama has worked alongside notable colleagues such as Takumi Sumida and Naoto Ohi. Their collaborative efforts have led to the successful development of innovative pharmaceutical solutions.

Conclusion

Takeshi Kodama's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…